This report also updates the classification and diagnosis of dry eye, critically evaluates the epidemiology, etiology, mechanism, and impact of this disorder, addresses its management and therapy, and proposes recommendations for the design of clinical trials to assess new pharmaceutical interventions for dry eye treatment.
This TFOS DEWS II initiative is very important, because dry eye disease is a global problem, afflicting over 30 million people in the United States alone, and is one of the most frequent causes of patient visits to eye care practitioners.
Translations of the TFOS DEWS II report will be offered in numerous languages, including but not limited to French, Italian, German, Spanish (sponsored by Allergan), Chinese, Korean, Portuguese, Vietnamese (sponsored by Novartis), Romanian, and Turkish (sponsored by SIFI).
TFOS thanks all the TFOS DEWS II members and sponsors who helped make this report a reality!
TFOS is a world leader in eye health education. TFOS' global collaboration among scientists, clinicians and industry professionals seeks action needed to help the world see better.
Visit TFOS on tearfilm.org
- 34.4 MB
- Release Date:
Safe to Download